Gangi Sumana, Fletcher J G, Nathan Mark A, Christensen Jared A, Harmsen William S, Crownhart Brian S, Chari Suresh T
University of Medicine and Dentistry of New Jersey, Newark, NJ, USA.
AJR Am J Roentgenol. 2004 Apr;182(4):897-903. doi: 10.2214/ajr.182.4.1820897.
Our purpose was to determine whether abdominal CT can detect pancreatic cancer before its clinical diagnosis.
Two radiologists interpreted in a blinded manner 62 CT scans in 28 pancreatic cancer patients that were obtained before histologic diagnosis and 89 CT scans in 89 control subjects and noted specific CT findings. The presence of pancreatic cancer was characterized as definite, suspicious, low probability, or normal. The scans of the pancreatic cancer patients were divided into four groups on the basis of the time interval preceding cancer diagnosis (0-2, 2-6, 6-18, or > 18 months), and one scan (closest to 18 months) was selected per patient per time interval. Sensitivity and specificity for pancreatic cancer and interobserver agreement for CT findings were calculated.
Radiologists agreed that CT findings definite or suspicious for pancreatic cancer were present in 50% of the scans obtained 2-6 and 6-18 months before the diagnosis of pancreatic cancer (3/6 and 4/8 scans, respectively), but they noted such CT findings in only 7% (1/15) of the scans obtained more than 18 months before diagnosis. Pancreatic duct dilatation and cutoff were early CT findings identified by both radiologists and were associated with near-perfect and substantial interobserver agreement (kappa = 0.84 and 0.76, respectively). Ninety-five percent confidence intervals of specificity for tumor absence ranged from 92% to 100%.
CT can detect a significant proportion of asymptomatic incident pancreatic cancers before the clinical diagnosis of pancreatic cancer. CT should be considered in screening at-risk patient populations. Pancreatic duct dilatation and cutoff are early findings associated with the development of pancreatic cancer and can be detected on CT with a high degree of reproducibility.
我们的目的是确定腹部CT能否在胰腺癌临床诊断之前检测出该疾病。
两名放射科医生以盲法解读了28例胰腺癌患者在组织学诊断之前获取的62份CT扫描图像,以及89名对照受试者的89份CT扫描图像,并记录了特定的CT表现。胰腺癌的存在被分为明确、可疑、低概率或正常。根据癌症诊断前的时间间隔(0 - 2、2 - 6、6 - 18或>18个月),将胰腺癌患者的扫描图像分为四组,每个时间间隔每位患者选择一份最接近18个月的扫描图像。计算胰腺癌的敏感性和特异性以及CT表现的观察者间一致性。
放射科医生一致认为,在胰腺癌诊断前2 - 6个月和6 - 18个月获取的扫描图像中,分别有50%(分别为3/6和4/8份扫描图像)存在明确或可疑的胰腺癌CT表现,但在诊断前超过18个月获取的扫描图像中,他们仅发现7%(1/15)有此类CT表现。胰管扩张和截断是两名放射科医生均发现的早期CT表现,且观察者间一致性接近完美和高度一致(kappa值分别为0.84和0.76)。肿瘤不存在的特异性的95%置信区间为92%至100%。
CT能够在胰腺癌临床诊断之前检测出相当比例的无症状偶发胰腺癌。对于高危患者群体的筛查应考虑使用CT。胰管扩张和截断是与胰腺癌发生相关的早期表现,可在CT上高度可重复地检测到。